BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishizuka T, Murotani T, Yamatodani A. Action of Modafinil Through Histaminergic and Orexinergic Neurons. Sleep Hormones. Elsevier; 2012. pp. 259-78. [DOI: 10.1016/b978-0-12-394623-2.00014-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Mucci F, Carpita B, Pagni G, Vecchia AD, Bjedov S, Pozza A, Marazziti D. Lifetime evolution of ADHD treatment. J Neural Transm (Vienna) 2021;128:1085-98. [PMID: 33993352 DOI: 10.1007/s00702-021-02336-w] [Reference Citation Analysis]
2 López-Amador N. Systemic exertion intolerance disease associated to neuroendocrine dysfunction and cortical atrophy: a case report. Fam Pract 2022:cmac060. [PMID: 35640045 DOI: 10.1093/fampra/cmac060] [Reference Citation Analysis]
3 Mereu M, Bonci A, Newman AH, Tanda G. The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology (Berl) 2013;229:415-34. [PMID: 23934211 DOI: 10.1007/s00213-013-3232-4] [Cited by in Crossref: 88] [Cited by in F6Publishing: 68] [Article Influence: 9.8] [Reference Citation Analysis]
4 Reichel CM, Gilstrap MG, Ramsey LA, See RE. Modafinil restores methamphetamine induced object-in-place memory deficits in rats independent of glutamate N-methyl-D-aspartate receptor expression. Drug Alcohol Depend 2014;134:115-22. [PMID: 24120858 DOI: 10.1016/j.drugalcdep.2013.09.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
5 van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate. Am J Geriatr Psychiatry 2021;29:51-62. [PMID: 32461027 DOI: 10.1016/j.jagp.2020.04.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
6 Hamilton MJ, Atalaia A, Mclean J, Cumming SA, Evans JJ, Ballantyne B, Jampana R, The Scottish Myotonic Dystrophy Consortium, Longman C, Livingston E, van der Plas E, Koscik T, Nopoulos P, Farrugia ME, Monckton DG. Clinical and neuroradiological correlates of sleep in myotonic dystrophy type 1. Neuromuscular Disorders 2022. [DOI: 10.1016/j.nmd.2022.02.003] [Reference Citation Analysis]
7 Takekawa D, Kushikata T, Kitayama M, Hirota K. Anesthetic management of a patient with narcolepsy by combination of total intravenous and regional anesthesia: a case report. JA Clin Rep 2017;3:37. [PMID: 29457081 DOI: 10.1186/s40981-017-0107-4] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Murillo-Rodríguez E, Barciela Veras A, Barbosa Rocha N, Budde H, Machado S. An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil. ACS Chem Neurosci 2018;9:151-8. [PMID: 29115823 DOI: 10.1021/acschemneuro.7b00374] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
9 Fiscon G, Conte F, Amadio S, Volonté C, Paci P. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis. Neurotherapeutics 2021. [PMID: 33987813 DOI: 10.1007/s13311-021-01064-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Reder AT, Feng X. How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms. J Interferon Cytokine Res 2014;34:589-99. [PMID: 25084175 DOI: 10.1089/jir.2013.0158] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]